Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregor Hutter

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2008
Heat shock factor 1 regulates lifespan as distinct from disease onset in prion diseaseAndrew D Steele, Gregor Hutter, Walker S Jackson, et al.
PNAS Nexus|November 11, 2025
Increase of Inhibitory Siglec receptors on T cells mitigates severe immune reactions during acute viral infectionsNatalia Rodrigues Mantuano, Anne Bärenwaldt, Mirza Sarcevic, et al.
Neuro-Oncology|February 15, 2013
IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survivalSeverina Leu, Stefanie von Felten, Stephan Frank, et al.
Journal of Neuropathology and Experimental Neurology|October 18, 2024
Multidimensional analysis of matched primary and recurrent glioblastoma identifies contributors to tumor recurrence influencing time to relapseTala Shekarian, Marie-Françoise Ritz, Sabrina Hogan, et al.
Nature Nanotechnology|November 8, 2016
Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissuesSaeid Zanganeh, Gregor Hutter, Ryan Spitler, et al.
Science Translational Medicine|October 25, 2019
Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockadeTala Shekarian, Eva Sivado, Anne-Catherine Jallas, et al.
Journal of Neuro-Oncology|November 19, 2016
Reverse phase protein arrays enable glioblastoma molecular subtypingGregor Hutter, Martin Sailer, Tej Deepak Azad, et al.
Frontiers in Immunology|June 17, 2022
COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical OutcomesBanafsheh Bigdelou, Mohammad Reza Sepand, Sahar Najafikhoshnoo, et al.
Nature|May 18, 2017
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunitySydney R Gordon, Roy L Maute, Ben W Dulken, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|August 14, 2019
Immunoengineering in glioblastoma imaging and therapySteven Zanganeh, Petrina Georgala, Claudia Corbo, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2008
Heat shock factor 1 regulates lifespan as distinct from disease onset in prion diseaseAndrew D Steele, Gregor Hutter, Walker S Jackson, et al.
PNAS Nexus|November 11, 2025
Increase of Inhibitory Siglec receptors on T cells mitigates severe immune reactions during acute viral infectionsNatalia Rodrigues Mantuano, Anne Bärenwaldt, Mirza Sarcevic, et al.
Neuro-Oncology|February 15, 2013
IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survivalSeverina Leu, Stefanie von Felten, Stephan Frank, et al.
Journal of Neuropathology and Experimental Neurology|October 18, 2024
Multidimensional analysis of matched primary and recurrent glioblastoma identifies contributors to tumor recurrence influencing time to relapseTala Shekarian, Marie-Françoise Ritz, Sabrina Hogan, et al.
Nature Nanotechnology|November 8, 2016
Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissuesSaeid Zanganeh, Gregor Hutter, Ryan Spitler, et al.
Science Translational Medicine|October 25, 2019
Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockadeTala Shekarian, Eva Sivado, Anne-Catherine Jallas, et al.
Journal of Neuro-Oncology|November 19, 2016
Reverse phase protein arrays enable glioblastoma molecular subtypingGregor Hutter, Martin Sailer, Tej Deepak Azad, et al.
Frontiers in Immunology|June 17, 2022
COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical OutcomesBanafsheh Bigdelou, Mohammad Reza Sepand, Sahar Najafikhoshnoo, et al.
Nature|May 18, 2017
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunitySydney R Gordon, Roy L Maute, Ben W Dulken, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|August 14, 2019
Immunoengineering in glioblastoma imaging and therapySteven Zanganeh, Petrina Georgala, Claudia Corbo, et al.
Pageof 6